Showing results (91-100 of 514) with videos related to

Sort By:
Pageof 52
Clinical Nursing Practice in Epilepsy|January 1, 1996
Adolescent psychosocial issues in epilepsyP Dean, J K Austin
Oncotarget|August 11, 2015
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line modelsChrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
Biochemical Pharmacology|March 1, 1982
Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamineC Brindley, A Gescher, S P Langdon, et al.
Molecular Cancer Therapeutics|January 24, 2007
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signalingPeter Mullen, David A Cameron, Max Hasmann, et al.
Scientific Reports|October 28, 2015
Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosisWim Verleyen, Simon P Langdon, Dana Faratian, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitorsIbrahim H Kankia, Poornima Paramasivan, Matthew Elcombe, et al.
Toxicology|February 1, 1985
Studies on the toxicity of the antitumour agent N-methylformamide in miceS P Langdon, D Chubb, A Gescher, et al.
International Journal of Cancer|September 27, 2005
Comparison of strategies targeting Raf-1 mRNA in ovarian cancerPeter Mullen, Fiona McPhillips, Brett P Monia, et al.
Biochemical Pharmacology|August 25, 1995
Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 12, 2016
Kinetic modelling of in vitro data of PI3K, mTOR1, PTEN enzymes and on-target inhibitors Rapamycin, BEZ235, and LY294002Alexey Goltsov, Ghassan Tashkandi, Simon P Langdon, et al.
Pageof 52